RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. (Q51426261)

5 April 2018

title

RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. (English)

1 reference

5 April 2018

0 references

Kevin K Frick

1

1 reference

5 April 2018

Kelly LaPlante

series ordinal

2

1 reference

5 April 2018

David A Bushinsky

series ordinal

3

1 reference

5 April 2018

publication date

21 June 2005

1 reference

5 April 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

5 April 2018

volume

289

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

F1005-11

1 reference

5 April 2018

The calciuria of increased fixed acid production in humans: Evidence against a role for parathyroid hormone and 1,25(OH)2-vitamin D

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

The skeleton as an ion exchange system: implications for the role of acid-base imbalance in the genesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Metabolic, but not respiratory, acidosis increases bone PGE(2) levels and calcium release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Regulation of the differentiation and function of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Pathophysiology of hypercalciuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Cytokines and related receptor-mediated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Regulatory mechanisms of osteoblast and osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Mechanism of acid-induced bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Urinary Calcium Excretion in Human Beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Bone buffering of acid and base in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Regulation of interleukin-6 production by prostaglandin E2 in fetal rat osteoblasts: role of protein kinase A signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Cytokine receptors: structures and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00420.2004

10.1152/AJPRENAL.00420.2004

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

15972386

1 reference

5 April 2018